Video & Transcript : 'cannabis labeling' :

Page 5 of 244
HI
Committee: House Health
Summary: The committee heard testimony on several health-related bills. HB 1864, which would require health insurance coverage for standard fertility preservation services for people undergoing medically necessary treatment, drew broad support from SHIPA, the Department of Health, HMSA, the Hawaii Association of Health Plans, and others. Testifiers emphasized that fertility preservation is routine coverage on the mainland and important for patients facing infertility from cancer or other treatment; one patient described incurring more than $20,000 in costs. The Insurance Division flagged possible Affordable Care Act issues, a potential conflict in the bill’s language about using patient history to determine limits, and a mismatch with state medical-necessity standards. Committee discussion also focused on whether the bill should apply to all women of childbearing age rather than a narrower age-based category. HB 2305 would require nutrition and metabolic education as part of physicians’ continuing medical education. The Hawaii Medical Board opposed the measure, arguing that CME should remain flexible and tailored to each physician’s specialty and warning that topic-specific mandates can expand over time. The Office of the Governor supported the bill, saying it would help the state’s rural health transformation application and could improve federal funding prospects, though the exact impact was unclear. Members questioned whether nutrition is already covered in medical training and whether the requirement should be limited to primary care physicians; the board said Hawaii currently has no topic-specific CME mandates and that physicians can already choose relevant courses. The committee also heard strong support for HB 1597, which would establish an Alzheimer’s disease research center at the University of Hawaii. Supporters from the university, the Alzheimer’s Association, AARP, and others said the center could attract federal research dollars, expand clinical trials, and help address the state’s high Alzheimer’s-related health costs. HB 2159, which appropriates funds for health care workforce development, also received broad support from the University of Hawaii, health systems, and advocacy groups, with no opposition noted. Finally, HB 2121, which would prohibit the sale and distribution of disposable electronic smoking devices, drew support from the Department of Health, youth advocates, and public health groups citing youth addiction, environmental waste, and fire hazards; the department said a separate bill, HB 1573, would be more comprehensive and better defined for enforcement and penalties. The committee ended with HB 1913, creating a veteran services mental health coordinator position at Tripler Army Medical Center, which was supported by veteran services officials and others who said veterans need better navigation and coordination for behavioral health care.
MN

Minnesota 2025-2026 Regular Session

House Commerce Finance and Policy Committee 3/26/26

Commerce Finance and Policy

Transcript Highlights:
  • <c> who</c><01:26:50.840><c> have</c> Representative West and others who have an interest in the cannabis
  • come up with something that will be added on then as maybe the final amendment and agreement for Cannabis
MN

Minnesota 2025-2026 Regular Session

Judiciary Committee Meeting - 2026-03-25

Judiciary Finance and Civil Law

Transcript Highlights:
  • This is a part of the Office of Cannabis<00:31:33.760><c> Management's</c><00:31:34.720><c> Agency</c
  • bill and it Cannabis Management's Agency bill and it will<00:31:36.159><c> just</c><00:31:36.320><c>
  • I'm the executive director for the Minnesota Office of Cannabis Management.
  • states that have prohibited cannabis, we track and trace every piece of cannabis from the point of its
  • , we track and trace every piece cannabis, we track and trace every piece of<00:32:13.679><c> cannabis
WA

Washington 2025-2026 Regular Session

House Agriculture & Natural Resources Jan 20th, 2026 at 10:30 am

Agriculture & Natural Resources

Transcript Highlights:
  • registration of a pesticide after a hearing if the director determines that the pesticide or its labeling
  • This bill authorizes licensed cannabis 18th.
  • It's just about authorizing agricultural cooperatives in the cannabis industry.
  • But, you know, there's been a lot of pushback on cannabis being an agricultural product, and I think
  • As we know, cannabis is an agricultural product.
Bills: HB2279 , HB2463 , HB1941 , HB2238
HI

Hawaii 2026 Regular Session

AEN-EDT, AEN Public Hearings 02-06-2026

Agriculture and Environment

Transcript Highlights:
  • </c> >> So that would be based on the label.
  • Um and I think the labels should unit.
  • </c><01:36:47.199><c> in</c> the only um things that is labeled in the only um things that is labeled
  • </c> further restrictions on the label. further restrictions on the label.
  • So it's not something that we are not following the label.
Bills: SB2350 , SB2349 , SB2407 , SB3320
Summary: The committee heard testimony on SP 2350, which would transfer oversight of the Department of Agriculture’s Agricultural Development Division and the aquaculture and livestock support services branch to the Agribusiness Development Corporation. The Department of Agriculture and ADC both testified, with ADC opposing the bill as written while supporting the goal of strengthening agriculture. ADC said the transfer could create federal operational and coordination risks, jeopardize federal funding and program continuity, and was unnecessary because ADC is a business development entity, not a regulatory agency. The Hawaii Farmers Union also expressed concern that moving the programs could weaken the department’s ability to access federal resources, while the Hawaii Farm Bureau submitted written testimony and the Hawaii Aquaculture and Aquaponics Association and H-Plan were noted as supporting the measure; the Hawaii Cattlemen’s Council was noted as opposing it. Much of the discussion focused on aquaculture’s economic potential and the role of regulation, permitting, and funding. Committee members questioned why aquaculture had not grown faster, citing current gross revenues of about $66 million last year, a prior high of $82 million, and a possible long-term target of $500 million. Testimony identified permitting and feed costs as major barriers, along with market conditions and water quality issues affecting producers. ADC described ongoing efforts on feed development, permitting streamlining, coastal-state collaboration on seaweed and restorative aquaculture, and national advocacy for more parity in seafood import standards. Members also pressed the Department of Agriculture on its leadership and priorities, criticizing the lack of bills and resources dedicated to aquaculture and asking whether the department should have more authority to pursue land purchases and development opportunities. The department said it relies on divisions and industry feedback for bill ideas, noted it funds an annual aquaculture survey, and said it was pursuing congressional earmarks and other funding for aquaculture parks, research, and export/import issues. ADC said it would work with the department if the bill passed, but that its current statute does not give it regulatory authority and any such change would require a statutory amendment.
OK

Oklahoma 2026 Regular Session

Alcohol, Tobacco and Controlled Substances REVISED: HB3851 - Added Feb 18th, 2026 at 10:30 am

Alcohol, Tobacco and Controlled Substances

Transcript Highlights:
  • And so this would just label serving size, and they would say how many servings were in that container
  • a thousand-milligram package, that each piece would be 100 milligrams, and that would be clearly labeled
  • Members, House Bill 3851 is a bill about the process of selling private label and how they're distributed
Bills: HB3334 , HB4248 , HB4454 , HB3851
OK

Oklahoma 2026 Regular Session

Alcohol, Tobacco and Controlled Substances REVISED: HB3851 - Added Feb 18th, 2026

Alcohol, Tobacco and Controlled Substances

Transcript Highlights:
  • And so this would just label serving size and they would say how many servings were in that container
  • been a 1,000-milligram package that each piece would be 100 milligrams, and that would be clearly labeled
  • Members, House Bill 3851 is a bill about the process of selling private label and how they're distributed
Bills: HB3334 , HB4248 , HB4454 , HB3851
Summary: The Tobacco, Alcohol, and Controlled Substances committee met with a quorum and considered several bills related to alcohol distribution and hemp/THC products. House Bill 3334, presented by Rep. Hays, would create a limited retail on-supply alcohol act allowing on-premise licensees to buy alcohol beverages from off-premise licensees. Supporters said it could help rural businesses facing strained supply chains and delayed deliveries after alcohol market changes; the committee voted to pass the bill. The committee then heard House Bill 4248, which would add protections to keep children from ingesting alcoholic drinks containing hemp with THC-like effects. Members discussed whether the bill might be amended further, but the author said the goal was to protect kids and preserve the bill’s current structure. The committee voted to pass HB 4248. House Bill 4450, presented by Rep. Newton, would regulate THC gummies and liquids by requiring serving-size labeling, limiting servings to 10 milligrams of THC each, and prohibiting child-attractive shapes such as animals, cartoons, or human forms. Members raised concerns about vague language like “reasonable resemblance” and about color restrictions, and the author said he was willing to work on those provisions. The committee voted to pass the bill. Finally, the committee considered House Bill 3851, which Rep. Marti said concerns the process for selling and distributing private label products and clarifies the ABLE Commission’s interpretation of current law. An amendment deleting Sections 1 and 3 was adopted without objection, and the committee then voted to pass the bill as amended. The meeting ended with the chair noting it was the last meeting of the year and adjourning.
FL

Florida 2026 Regular Session

Health Policy Feb 11th, 2026

Health Policy

Transcript Highlights:
  • As Cannabis Action Network, access, affordability, and safety are our priorities.
  • It does update low-THC cannabis, and it also enhances the department's ability to respond quickly when
  • And Senator Davis, no, they're not FDA-approved uses, but they are being used off-label. ...but they
  • are being used off-label.
  • Jody James, Florida Cannabis Action Network, you're recognized. Thank you. I just want to...
Bills: S0688 , S1414 , S0186 , S0902 , S0196 , S1574 , S0878 , S1092 , S1032 , S1684 , S1686 , S1760
Summary: The committee took up several health-related bills and confirmations. It first heard SB 1414 on congenital cytomegalovirus education, which would require the Department of Health to develop and distribute educational materials to expectant and new parents through maternity, prenatal, newborn, and OB-GYN settings; an amendment removed a section on required instruction for medical professionals, and the bill was reported favorably as a committee substitute. The committee then approved a block of appointees on tabs 2 through 7 and separately confirmed Chavon Harris as Secretary of the Agency for Health Care Administration after her testimony on Medicaid accountability, transparency, managed care oversight, rural health, behavioral health, and the state’s technology modernization efforts. Senators asked Harris about Hope Florida, Medicaid redeterminations, the CORE project, an anti-marijuana ad campaign at DCF, and compliance with a federal Medicaid-related court order; she said she would follow up on some issues. The confirmation was recommended favorably, with Senator Berman voting no. The committee next passed SB 186 on student health and safety, which expands epilepsy and seizure-disorder training requirements to more school personnel, including bus drivers and charter school staff, and requires seizure-first-aid posters and updated Department of Health education efforts. It also approved SB 902 on Department of Health issues after amendments narrowed the bill’s scope and added provisions on medical marijuana regulation, early childhood intervention, practitioner accountability, and autism workforce development; one speaker raised concerns about marijuana dispensary location restrictions and low-THC ratios. SB 196 creating a uterine fibroid research database was also reported favorably after an amendment protecting patient privacy; the bill drew emotional testimony from a patient describing severe symptoms and the need for more research. SB 688 on naturopathic medicine was approved after committee discussion about scope of practice, referral obligations, and whether naturopathic care should be adjunctive to conventional medicine; supporters described complementary care and access issues, while opponents worried about delayed treatment for serious disease. Later, the committee passed SB 1574, “Maddie’s Law,” to add biliary atresia screening to newborn screening using the same blood specimen already collected at birth and to launch an education campaign; parents of a child affected by the disease testified that earlier screening could have prevented severe harm. SB 878 on clinical laboratory personnel was reported favorably to address staffing shortages by allowing Florida to rely more directly on federal CLIA standards for qualified lab workers. SB 1092 on podiatric medicine was approved after an amendment narrowed it to cellular/tissue-based products and podiatrists’ use of certain therapies; the bill also addresses continuing education, informed consent, and advertising disclosures. SB 1032 on medical marijuana was amended and passed, aligning physician certification and card renewal timelines, setting 70-day and 35-day supply limits, and reducing the fee for honorably discharged veterans while preserving funding for FAMU; Senator Harrell opposed it, saying the longer timeframes were too much of an expansion. The committee also heard SB 1760 on Medicaid coverage transparency from Senator Brodeur, who said the bill focuses on accountability and fiscal responsibility, but the transcript cuts off before further discussion or action on that measure.
HI

Hawaii 2026 Regular Session

AGR Public Hearing - Fri Mar 20, 2026 @ 9:30 AM HST

Agriculture & Food Systems

Transcript Highlights:
  • I think it's fair that we have enough studies to tell us the needs of why we should be labeling locally
  • I think it's fair that we have enough studies to tell us the needs of why we should be labeling locally
  • And the other was to label and identify which lei was locally made.
  • And also setting labeling standards for lei. And it already has an effective date in that draft.
OK

Oklahoma 2026 Regular Session

Administrative Rules May 4th, 2026

Administrative Rules

Summary: The committee considered three resolutions, all presented by Chairman Kendrick with full PCS substitutes. H.J.R. 1096 approved a medical marijuana rule that had originally been treated as a major rule but was later determined not to be one; members asked no questions and the resolution was adopted unanimously. H.J.R. 1099 was described as a direct result of H.B. 1576 from the prior session concerning Oklahoma Health Care Authority rules; it also drew no questions and passed unanimously. H.J.R. 1100 addressed a rule from the Oklahoma Management and Enterprise Services that was discovered late to be a major rule; after brief discussion and no substantive questions, it too passed unanimously. During the meeting, members voted on each resolution after motions for adoption and do pass. The recorded votes were unanimous in favor on all three measures, with no nay votes. After H.J.R. 1100 passed, Chairman Kendrick noted there would be one more committee meeting the next morning at 9 a.m. to address a late-arriving resolution, and he offered to discuss the late major-rule issue with Representative Chapman after adjournment.
FL

Florida 2026 Regular Session

Appropriations Committee on Health and Human Services Feb 18th, 2026

Appropriations Committee on Health and Human Services

Transcript Highlights:
  • particular thing, this is what you would normally call, and we know in medicine is usually the term off-label
  • And we know in medicine is usually the term off-label, and we do this with many other medications as
  • The bill updates the statutory definition of low-THC cannabis by removing the dried flower specification
  • so that it applies to all forms of cannabis, except edibles, and revises the CBD potency requirement
  • with Senator Garcia regarding the Department of Health bill, but I am Melissa with the holistic cannabis
Bills: S0042 , S0196 , S0878 , S0902 , S0914 , S1092 , S1168 , S1340 , S1404 , S1414 , S1684 , S1686
Summary: The Appropriations Committee on Health and Human Services met to hear and vote on a series of health, human services, and education-related bills, along with a presentation of the committee’s proposed HHS budget. The budget was described as increasing by more than $2.1 billion over the current base, with major funding highlighted for Medicaid and KidCare, rural health, provider rate increases, child welfare, mental health and substance use, opioid treatment, Alzheimer’s initiatives, cancer research, ADAP, veterans’ services, and IT modernization. Public testimony on the budget focused heavily on AIDS Drug Assistance Program funding and concerns about Department of Health changes affecting access, premium assistance, notice, and continuity of care for people living with HIV/AIDS. Among the bills reported favorably were measures on podiatric medicine and tissue-based products (SB 1092), background screening and clearinghouse procedures (SB 1168), child protective investigations involving specific medical diagnoses and second opinions (SB 42), clinical laboratory personnel licensure standards (SB 878), uterine fibroid data tracking and research (SB 196), medical marijuana treatment center oversight and related health provisions (SB 902), dyslexia and dyscalculia screening and intervention in schools (SB 1340), memory care licensure for assisted living facilities (SB 1404), congenital CMV education materials (SB 1414), Parkinson’s disease registry and related public records exemption bills (SB 1684 and SB 1686), and occupational therapy dry needling licensure standards (SB 914). Several bills were amended before passage, including SB 1092, SB 42, SB 902, SB 1684, and SB 1404. Testimony generally came from professional associations, advocacy groups, and affected stakeholders, with support voiced for most measures. The committee adopted amendments on the floor, heard no opposition during debate on the bills described, and then voted to report each measure favorably. At the end of the meeting, senators requested to be recorded in the affirmative on selected bills, and the committee adjourned.
WA

Washington 2025-2026 Regular Session

House Consumer Protection & Business Jan 30th, 2026 at 08:00 am

Consumer Protection & Business

Transcript Highlights:
  • Turning to labeling and packaging requirements: The bill establishes that kratum products contain a label
  • And because cannabis is something that sits in this committee, I'm going to equate it to cannabis.
  • that's on all cannabis products in the state of Washington, edible cannabis products.
  • products, or participating cannabis licensees could be preparing and selling the cannabis products to
  • This is expansion of cannabis.
TX

Texas 89th Regular

Health and Human Services Apr 30th, 2025

Health & Human Services

Transcript Highlights:
  • This bill would essentially require simply a label affixed to the bottle or container.
  • I’m here today to offer insight regarding warning labels on opioid prescriptions.
  • No warning label about possible respiratory depression is affixed.
  • No warning label about possible respiratory depression is affixed.
  • I have done... label about possible respiratory depression is affixed.
Summary: The committee met with a quorum and announced it would vote on pending bills at 10:30, with public testimony limited to two minutes. It first took up Senate Bill 905, a TDLR cleanup bill on licensing regulation of speech-language pathologists and audiologists. Senator Zafferini said the committee substitute would streamline advisory board consultation, remove obsolete provisional licenses, and allow any licensed physician to authorize hearing instruments for minors; the substitute was adopted and the bill left pending. The committee then heard House Bill 451, which would require universal screening for commercial sexual exploitation risk for children in DFPS conservatorship and youth under TJJD jurisdiction. The author and witnesses from Children at Risk, the Fort Bend Anti-Trafficking Collective, and Texas CASA supported the bill as a prevention tool with existing infrastructure and training; the committee adopted the substitute and left the bill pending. The committee next considered Senate Bill 466, which would clarify that families may request a fetal death certificate at any gestational age, while keeping existing filing requirements for physicians. A constituent father testified about losing his 11-week-old daughter and being told he could not obtain a certificate, which he said prevented funeral arrangements; the substitute was adopted and the bill left pending. Senate Bill 2311 followed, requiring residential treatment centers to have a written agreement with the school that will educate resident children before becoming operational. The author cited a local dispute where an RTC and school district lacked communication, and witnesses from Texas CASA and Disability Rights Texas supported clearer educational planning while suggesting the Education Code may need conforming changes; the bill was left pending. The committee then heard Senate Bill 2826, known as Alyssa’s Law, which would create a statewide education program on medical child abuse for medical students, health care professionals, and CPS caseworkers. The author and Sheriff Bill Weyburn described Alyssa’s case as involving repeated unnecessary surgeries and argued the bill would improve awareness and early identification, while several witnesses and members raised concerns about false accusations, impacts on medically fragile children, and the need for scientific, peer-reviewed training and safeguards. After extensive discussion, the chair left the bill pending. The committee also heard House Bill 136, which would add certified lactation consultants as Medicaid providers to expand breastfeeding support; witnesses from lactation and nutrition fields said the bill would improve access, maternal and infant health, and long-term savings, and the bill was left pending. Finally, the committee took up Senate Bill 2805, a surprise-billing/arbitration measure that would clarify provider identifiers and shift arbitration costs to the losing party. The author said the substitute was a legislative counsel draft with no substantive difference, and witnesses from the Texas Medical Association, Texas Society of Anesthesiologists, and U.S. Anesthesia Partners supported the bill as a modest improvement that would reduce administrative confusion and make arbitration fairer without weakening patient protections. Members discussed how arbitration costs affect settlement behavior and how to define the “winner” in close cases. The bill was heard but not voted out during this segment.